Darden posts Q3 sales up 6.8% to $3.0B; adjusted EPS $2.62 (+12%); authorizes $1B buyback

DARDEN RESTAURANTS INC

2024-Q3 EPS reported $5.95 revenue$8,432,700,000

Total sales $3.0B (+6.8% YoY); blended same-restaurant sales -1.0%; LongHorn +2.3%, Olive Garden -1.8%.
Reported diluted EPS $2.60; adjusted diluted EPS $2.62 (+12% YoY), excluding $0.02 Ruth's Chris costs.
Board declared quarterly dividend of $1.31/share, payable May 1, 2024 to holders of record Apr 10.
Authorized new $1B share repurchase program, replacing prior authorization; repurchased $33M in Q3.
FY2024 outlook: sales ~$11.4B, adjusted EPS $8.80-$8.90, same-restaurant sales growth 1.5%-2.0%.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

DARDEN RESTAURANTS INC reported fiscal 2024 results: EPS $8.80 to $8.90. Guidance reaffirmed.

Period: fiscal 2024
EPS: $8.80 to $8.90
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

Adjusted diluted net earnings per share from continuing operations of $8.80 to $8.90, excluding approximately $0.35, after-tax, of Ruth's Chris transaction and integration related costs

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

DARDEN RESTAURANTS INC reported financial results for the third quarter ended February 25, 2024.

Period: the third quarter ended February 25, 2024
Result: reported results

Exact text from the filing

Darden Restaurants, Inc. (NYSE:DRI) today reported its financial results for the third quarter ended February 25, 2024.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

DARDEN RESTAURANTS INC filing history →

Source: SEC EDGAR

accession 0000940944-24-000011

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.